Tadalafil
| Advanced search |
- About 5 results found and you can help!
Tadalafil is a PDE5 inhibitor, currently marketed in pill form for treating erectile dysfunction (ED) under the name Cialis; and under the name Adcirca for the treatment of pulmonary arterial hypertension. On 10.2011 FDA approved Cialis for treatment the signs and symptoms of benign prostatic hyperplasia (BPH) as well as a combination of BPH and erectile dysfunction (ED) when the conditions coincide. It initially was developed by the biotechnology company ICOS, and then again developed and marketed world-wide by Lilly ICOS, LLC, the joint venture of ICOS Corporation and Eli Lilly and Company. Cialis tablets, in 5 mg, 10 mg, and 20 mg doses, are yellow, film-coated, and almond-shaped. The approved dose for pulmonary arterial hypertension is 40 mg (two 20-mg tablets) once daily.
- See also: Wikipedia
- Related: Add a related term
| Tadalafil bound to proteins Tadalafil bound to proteins www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=CIA - Web |
| National Institutes of Health - Medlineplus National Institutes of Health - Medlineplus www.nlm.nih.gov/medlineplus/druginfo/meds/a604008.html - Web |
| Material Safety Data Sheet PDF file Material Safety Data Sheet PDF file ehs.lilly.com/msds/msds_tadalafil_tablets.pdf - Web |
Average relevance
| Official Cialis (Tadalafil) Website Official Cialis (Tadalafil) Website www.cialis.com - Web |
| U.S. National Library of Medicine: Drug Informatio... U.S. National Library of Medicine: Drug Information Portal - Tadalafil druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Tadalafil - Web |
